Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 573,626 |
| Open | 45.19 |
| Bid (Size) | 36.63 (100) |
| Ask (Size) | 71.35 (100) |
| Prev. Close | 45.61 |
| Today's Range | 44.35 - 45.67 |
| 52wk Range | 32.83 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
1 Growth Stock to Stash and 2 We Turn Down
July 15, 2026
3 Reasons to Avoid SUPN and 1 Stock to Buy Instead
June 16, 2026
3 Stocks Under $50 with Open Questions
May 21, 2026
3 Small-Cap Stocks That Concern Us
May 18, 2026
3 Growth Stocks We Approach with Caution
May 15, 2026
Supernus (SUPN) Q1 2026 Earnings Transcript ↗
May 05, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 44.63
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 07/31/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.37B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.